Danielle Rosemond

Danielle Rosemond practices at Glen Cove Hospital in Glen Cove, New York, part of Northwell Health.

Danielle Rosemond's NPI, 1083013635, was assigned on August 20, 2014. Danielle Rosemond holds New York license 285287.

Danielle Rosemond's primary practice is Glen Cove Hospital, at 101 St Andrews Lane, Glen Cove, NY 11542 in Nassau County. The practice phone is (516) 674-7300.

Danielle Rosemond's primary practice is Glen Cove Hospital in Glen Cove, New York, part of Northwell Health. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Danielle Rosemond to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Rosemond practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Danielle Rosemond's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Danielle Rosemond is licensed in New York.

CMS data shows 458 Medicare services from Danielle Rosemond across 4 procedure codes in 2024, for 243 Medicare patients. Medicare paid $41,550 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Danielle Rosemond in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Danielle Rosemond's median patient age at 77, with 51% women.

In 2024, Danielle Rosemond wrote 54 Medicare Part D claims for 32 patients. 87% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $18 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Danielle Rosemond for performance year 2024, reported through an alternative payment model (APM). Danielle Rosemond accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Danielle Rosemond in 2019. Danielle Rosemond's most frequent co-authors are Ashwad Afzal, MD and Eshan Patel, MD.

CMS Open Payments shows 9 general payments to Danielle Rosemond from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Theravance Biopharma, Inc. paid the most, $125.